[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630627":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":32,"responsibleParty":52,"collaborators":10,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":66,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Methodist Health System","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Underwent ERCP",null,"Underwent ERCP between January 1, 2000 through December 31, 2025",[13],"Other: Patients undergoing ERCPs at Methodist Dallas Medical Center",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Patients undergoing ERCPs at Methodist Dallas Medical Center","The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.",[9],[20],{"name":21,"affiliation":5,"role":22},"Prashant Kedia, MD","PRINCIPAL_INVESTIGATOR",[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Crystee Cooper, DHEd","CONTACT","214-947-1280","ClinicalResearch@mhd.com",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":28},"Kavya Mankulangara","214-947-4604",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Methodist Dallas Medical Center- Clinical Research Institute","RECRUITING","Dallas","Texas","75203","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-96.80667,32.78306,{"lat":45,"lon":44},[48,51],{"name":49,"role":26,"phone":50,"phoneExt":10,"email":28},"Colette Ngo Ndjom","214-947-1289",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":28},{"type":53,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100630627","endoscopic-retrograde-cholangiopancreatography-100630627",false,"NCT07490132","Endoscopic Retrograde Cholangiopancreatography","Endoscopic Retrograde Cholangiopancreatography Patient Registry","Inclusion Criteria:\n\nPatients \\>15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025\n\nExclusion Criteria:\n\nPatients \\\u003C15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.","ALL","15 Years",{"count":64,"type":65},100,"ESTIMATED","25 Years","OBSERVATIONAL","The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.",[70],"Gastro-Intestinal Disorder","2026-03-18",{"date":73,"type":74},"2026-03-24","ACTUAL",{"date":76,"type":65},"2026-02",{"date":78,"type":65},"2028-02",{"name":5,"class":6},1]